Dual-listed AFT Pharmaceuticals has reported a $2.45 million interim net loss, down 235% on the prior period’s $1.8m profit, as major customers lowered their inventories and Asian sales were hurt by a prolonged doctors’ strike. It made an operating loss of $1.8m for the first half, compared to
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
